Boston Partners’s Alpine Immune Sciences Inc ALPN Stock Holding History

Boston Partners’s Portfolio ALPN Stock Details ALPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-23,101	Closed	-$916K	–	810
2024 Q1	$916K	Buy	+23,101	New	+$682K	﹤0.01%	583

Boston Partners's ALPN Position: Q2 2024 in Review

Boston Partners sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 23,101 shares — an estimated $916K sold.

Boston Partners first reported a position in ALPN in Q1 2024 and held it in 1 quarter. The position peaked at $916K in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

Boston Partners reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
Boston Partners sold 23,101 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $916K.
Boston Partners first reported a position in Alpine Immune Sciences Inc in Q1 2024 and held it in 1 quarter.
Boston Partners's Alpine Immune Sciences Inc position peaked at $916K in Q1 2024.
0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on Boston Partners's 13F filing for Q2 2024, filed 14 Aug 2024.